Drug addiction is associated with leukocyte telomere length

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Yang, Zhaoyang ^a   Ye, Junyi ^a   Li, Candong ^b   Zhou, Daizhan ^e   Shen, Qin ^c   Wu, Ji ^e   Cao, Lan ^a   Wang, Ting ^c   Cui, Daxiang ^e   He, Shigang ^e   Qi, Guoyang ^d   He, Lin ^a,c,e   Liu, Yun ^a,f  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d Wuxi Mental Health Center   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT;

ADDICTION; ADULT; ARTICLE; COHORT ANALYSIS; DRUG EFFECT; FEMALE; GENETICS; HUMAN; LEUKOCYTE; MALE; METABOLISM; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; TELOMERE; TELOMERE SHORTENING;

ADULT; ANALGESICS, OPIOID; COHORT STUDIES; DIAZEPAM; FEMALE; HEROIN; HUMANS; HYPNOTICS AND SEDATIVES; LEUKOCYTES; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; SUBSTANCE-RELATED DISORDERS; TELOMERE; TELOMERE SHORTENING;

EID: 84875780157     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01542     Document Type: Article

References (35)

1. Blackburn, E. H. Switching and signaling at the telomere. Cell 106, 661-673 (2001). (Pubitemid 32900658)
2. de Lange, T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes & development 19, 2100-2110 (2005). (Pubitemid 41330312)
3. Autexier, C. & Lue, N. F. The structure and function of telomerase reverse transcriptase. Annual review of biochemistry 75, 493-517 (2006). (Pubitemid 44118041)
4. Panossian, L. A. et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiology of aging 24, 77-84 (2003). (Pubitemid 35454145)
5. von Zglinicki, T. et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Laboratory investigation; a journal of technical methods and pathology 80, 1739-1747 (2000).
6. Reece, A. S. Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction includingmulti-system ageing. Medical hypotheses 75, 613-619 (2010).
7. Mitrovic, S. M., Dickov, A., Vuckovic, N., Mitrovic, D. & Budisa, D. The effect of heroin on verbal memory. Psychiatria Danubina 23, 53-59 (2011).
8. Sudai, E. et al. High cocaine dosage decreases neurogenesis in the hippocampus and impairs working memory. Addiction biology 16, 251-260 (2011).
9. Grella, C. E. & Lovinger, K. Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addictive behaviors 37, 306-312 (2012).
10. Reece, A. S. Differing age related trajectories of dysfunction in several organ systems in opiate dependence. Aging clinical and experimental research 24, 85-96 (2012).
11. Gil, M. E. & Coetzer, T. L. Real-time quantitative PCR of telomere length. Molecular biotechnology 27, 169-172 (2004). (Pubitemid 41490600)
12. Imam, T. et al. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants. J Acquir Immune Defic Syndr 60, 495-502 (2012).
13. Shen, Q. et al. Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations. The Journal of clinical endocrinology and metabolism 97, 1371-1374 (2012).
14. Blackburn, E.H. Structure and function of telomeres. Nature 350, 569-573 (1991). (Pubitemid 21912269)
15. Calado, R. T. & Young, N. S. Telomere diseases. The New England journal of medicine 361, 2353-2365 (2009).
16. Aviv, A. Telomeres and human somatic fitness. The journals of gerontology. Series A, Biological sciences and medical sciences 61, 871-873 (2006). (Pubitemid 44260173)
17. Mather, K. A., Jorm, A. F., Parslow, R. A. & Christensen, H. Is telomere length a biomarker of aging? A review. The journals of gerontology. Series A, Biological sciences and medical sciences 66, 202-213 (2011).
18. Mehra, R., Moore, B. A., Crothers, K., Tetrault, J. & Fiellin, D. A. The association between marijuana smoking and lung cancer: a systematic review. Archives of internal medicine 166, 1359-1367 (2006). (Pubitemid 44036347)
19. Kovacic, P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Medical hypotheses 64, 350-356 (2005). (Pubitemid 40022676)
20. Zhou, J. F. et al. Heroin abuse and nitric oxide, oxidation, peroxidation, lipoperoxidation. Biomedical and environmental sciences : BES 13, 131-139 (2000).
21. Yamamoto, B. K., Moszczynska, A. & Gudelsky, G. A. Amphetamine toxicities: classical and emerging mechanisms. Annals of the New York Academy of Sciences 1187, 101-121 (2010).
22. Sarafian, T. A., Magallanes, J. A., Shau, H., Tashkin, D. & Roth, M. D. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. American journal of respiratory cell and molecular biology 20, 1286-1293 (1999). (Pubitemid 129503247)
23. Oikawa, S. & Kawanishi, S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS letters 453, 365-368 (1999). (Pubitemid 29326680)
24. von Zglinicki, T. Oxidative stress shortens telomeres. Trends in biochemical sciences 27, 339-344 (2002). (Pubitemid 34756516)
25. Takakura, M., Kyo, S., Inoue, M.,Wright, W. E. & Shay, J. W. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Molecular and cellular biology 25, 8037-8043 (2005). (Pubitemid 41262997)
26. Akiyama, M. et al. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer research 63, 18-21 (2003). (Pubitemid 36070412)
27. Cong, Y. & Shay, J. W. Actions of human telomerase beyond telomeres. Cell research 18, 725-732 (2008). (Pubitemid 351948231)
28. Pan, J. et al.Oxidative stress in heroin administered mice and natural antioxidants protection. Life sciences 77, 183-193 (2005). (Pubitemid 40603503)
29. Shalev, I. Early life stress and telomere length: Investigating the connection and possible mechanisms: A critical survey of the evidence base, research methodology and basic biology. BioEssays : news and reviews inmolecular, cellular and developmental biology 34, 943-952 (2012).
30. Surtees, P. G. et al. Life stress, emotional health, and mean telomere length in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. The journals of gerontology. Series A, Biological sciences andmedical sciences 66, 1152-1162 (2011).
31. Malan, S., Hemmings, S., Kidd, M., Martin, L. & Seedat, S. Investigation of telomere length and psychological stress in rape victims. Depression and anxiety 28, 1081-1085 (2011).
32. Entringer, S. et al. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proceedings of the National Academy of Sciences of the United States of America 108, E513-518 (2011).
33. Droge, W. Oxidative stress and aging. Advances in experimental medicine and biology 543, 191-200 (2003). (Pubitemid 38183725)
34. Luo, J. et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 369, 2015-2020 (2007). (Pubitemid 46899161)
35. Gartner, C. E. et al. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 369, 2010-2014 (2007). (Pubitemid 46899160)